Yousif Capital Management LLC bought a new position in Waystar Holding Corp. (NASDAQ:WAY – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 34,390 shares of the company’s stock, valued at approximately $1,304,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. raised its position in Waystar by 224.6% in the 1st quarter. Raymond James Financial Inc. now owns 132,980 shares of the company’s stock valued at $4,968,000 after purchasing an additional 92,007 shares during the last quarter. MetLife Investment Management LLC raised its holdings in shares of Waystar by 73.8% in the first quarter. MetLife Investment Management LLC now owns 46,045 shares of the company’s stock valued at $1,720,000 after buying an additional 19,552 shares during the last quarter. Corebridge Financial Inc. raised its holdings in shares of Waystar by 79.9% in the first quarter. Corebridge Financial Inc. now owns 38,609 shares of the company’s stock valued at $1,442,000 after buying an additional 17,149 shares during the last quarter. Trexquant Investment LP acquired a new position in Waystar during the 1st quarter worth about $980,000. Finally, State of Wyoming bought a new stake in Waystar during the 1st quarter worth about $54,000.
Insider Buying and Selling
In other news, insider Eric L. (Ric) Sinclair III sold 9,701 shares of the company’s stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $32.82, for a total value of $318,386.82. Following the completion of the sale, the insider directly owned 474,826 shares of the company’s stock, valued at $15,583,789.32. This represents a 2.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CTO Christopher L. Schremser sold 8,623 shares of the stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $30.41, for a total transaction of $262,225.43. Following the completion of the sale, the chief technology officer owned 422,371 shares in the company, valued at $12,844,302.11. This represents a 2.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,372 shares of company stock valued at $2,030,623 over the last three months. Company insiders own 4.10% of the company’s stock.
Waystar Price Performance
Analysts Set New Price Targets
WAY has been the topic of a number of research reports. Barclays reduced their target price on shares of Waystar from $56.00 to $42.00 and set an “overweight” rating on the stock in a research report on Monday, December 8th. Wall Street Zen downgraded Waystar from a “buy” rating to a “hold” rating in a report on Saturday, November 29th. Weiss Ratings reissued a “hold (c)” rating on shares of Waystar in a research note on Wednesday, October 8th. Citizens Jmp assumed coverage on Waystar in a research report on Thursday, September 18th. They set a “mkt outperform” rating and a $48.00 target price for the company. Finally, Baird R W upgraded Waystar to a “strong-buy” rating in a report on Friday, September 5th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Waystar presently has a consensus rating of “Buy” and an average price target of $47.57.
Check Out Our Latest Research Report on Waystar
About Waystar
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
See Also
- Five stocks we like better than Waystar
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
